Last reviewed · How we verify

Influenza — Treatment Landscape & Competitive Intelligence

Influenza (Infectious Disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Infectious Disease 10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Influenza, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Test formulation (Treatment A) test-formulation-treatment-a Pfizer Enzyme inhibitor Specific enzyme Not yet determined
Xofluza BALOXAVIR MARBOXIL Roche 2018-01-01
Avigan FAVIPIRAVIR Toyama Chemical Co., Ltd. 2014-01-01
Relenza ZANAMIVIR GSK Neuraminidase Inhibitor [EPC] Sialidase 3 1999-01-01
PF-07852352 Influenza saRNA 1 pf-07852352-influenza-sarna-1 Pfizer antisense oligonucleotide influenza virus
PF-07914705 Influenza saRNA pf-07914705-influenza-sarna Pfizer RNA-based therapy influenza virus
PF-07836395 Influenza saRNA pf-07836395-influenza-sarna Pfizer Unknown Unknown
PF-07915048 Influenza saRNA pf-07915048-influenza-sarna Pfizer RNA-based therapy influenza virus
PF-07871987 Influenza saRNA pf-07871987-influenza-sarna Pfizer RNA-based therapeutic influenza virus
PF-07836394 Influenza saRNA pf-07836394-influenza-sarna Pfizer unknown unknown

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 9 drugs in Influenza
  2. Daiichi Sankyo · 1 drug in Influenza
  3. GSK · 1 drug in Influenza
  4. Roche · 1 drug in Influenza
  5. Toyama Chemical Co., Ltd. · 1 drug in Influenza
  6. Women and Infants Hospital of Rhode Island · 1 drug in Influenza
  7. · 1 drug in Influenza
  8. Zheng Liu · 1 drug in Influenza

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Influenza:

Cite this brief

Drug Landscape (2026). Influenza — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/influenza. Accessed 2026-05-13.

Related